Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression. (Q38922538)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression. |
scientific article |
Statements
Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression (English)
Te-Sheng Chang
Wei-Chi Su
Kam-Fai Lee
Tao-Hsin Tung
Jun-Jen Liu
Shui-Yi Tung
Liang-Mou Kuo
Pey-Jium Chang
1 January 2015